Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gantenerumab
Biotech
Scientists reflect on Roche's Alzheimer's failure a year later
A year after Roche's Alzheimer’s drug failed a phase 3 trial, the data are being published, giving scientists a chance to reflect on what was learned.
Annalee Armstrong
Nov 15, 2023 5:00pm
Fierce Biotech's Rotten Tomatoes of 2022
Dec 19, 2022 3:00am
Roche thins Alzheimer's program after phase 3 failure
Dec 1, 2022 12:52pm
Eisai makes the case for lecanemab after 2nd patient death
Nov 29, 2022 7:50pm
Roche Alzheimer's fail has industry circling the wagons
Nov 15, 2022 11:02am
Roche's anti-amyloid antibody fails phase 3 Alzheimer's trials
Nov 14, 2022 5:44am